ITCC-085 Aurora Kinase A

  • Innovative Therapies
    for Children with Cancer in Europe
  • Contact us

ITCC-085 Aurora Kinase A

A Phase 1 Study of Aurora Kinase A Inhibitor LY3295668 Erbumine as a Single Agent and in Combination in Patients With Relapsed/Refractory Neuroblastoma

Promotor Name : Eli Lilly

Investigator Name : 

Trial registered on NCT04106219